AML1 overexpression and/or mutations should be checked in trisomy 21 patients with megakaryocytic leukemia Leukemia (2003) TO THE EDITOR Some years ago, we hypothesised that a gene implicated in megakaryocytic progenitor maturation and/or differentiation should sit in chromosome 21, and AML1 was noted as a candidate gene. 1 A recent wealth of data has come since. On one hand, recent papers [2] [3] [4] have demonstrated AML1 to be involved in familial platelet disorder with predisposition to leukemia. AML1 5 and CBFB interact with SCL/TAL1, 6 and the critical role of SCL in megakaryopoiesis has recently been pointed out. 7 On the other hand, the risk of acute megakaryocytic leukemia (M7-ANLL) is 500-1000 times greater in trisomy 21 patients. 1, 8 We therefore suggest that forthcoming cases of M7-ANLL in trisomy 21 patients be checked for possible AML1 overexpression and/or mutations. 
